Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiency.

× No keyword cloud information.

14 in total

Review 1. Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors: Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal: Antioxid Redox Signal Date: 2011-04-10 Impact factor: 8.401

Review 2. Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.

Authors: Kara R Vogel; Phillip L Pearl; William H Theodore; Robert C McCarter; Cornelis Jakobs; K Michael Gibson
Journal: J Inherit Metab Dis Date: 2012-06-28 Impact factor: 4.982

3. Further evaluation of Vigabatrin therapy in 4-hydroxybutyric aciduria.

Authors: C Jakobs; T Michael; E Jaeger; J Jaeken; K M Gibson
Journal: Eur J Pediatr Date: 1992-06 Impact factor: 3.183

4. Efficacy of vigabatrin intervention in a mild phenotypic expression of succinic semialdehyde dehydrogenase deficiency.

Authors: M Casarano; M G Alessandrì; G S Salomons; E Moretti; C Jakobs; K M Gibson; G Cioni; R Battini
Journal: JIMD Rep Date: 2011-09-06

5. 4-Hydroxybutyric aciduria: clinical findings and vigabatrin therapy.

Authors: G Uziel; P Bardelli; C Pantaleoni; M Rimoldi; M Savoiardo
Journal: J Inherit Metab Dis Date: 1993 Impact factor: 4.982

6. Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency.

Authors: K M Gibson; C Jakobs; H Ogier; L Hagenfeldt; K E Eeg-Olofsson; O Eeg-Olofsson; F Aksu; H P Weber; E Rossier; B Vollmer
Journal: J Inherit Metab Dis Date: 1995 Impact factor: 4.982

Review 7. A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.

Authors: J Srinivasan; A Richens
Journal: Drug Saf Date: 1994-05 Impact factor: 5.606

8. Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.

Authors: I Knerr; P L Pearl; T Bottiglieri; O Carter Snead; C Jakobs; K M Gibson
Journal: J Inherit Metab Dis Date: 2007-04-24 Impact factor: 4.982

9. Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients.

Authors: Ina Knerr; K Michael Gibson; Cornelis Jakobs; Phillip L Pearl
Journal: CNS Spectr Date: 2008-07 Impact factor: 3.790

Review 10. Physiology and pathophysiology of organic acids in cerebrospinal fluid.

Authors: G F Hoffmann; W Meier-Augenstein; S Stöckler; R Surtees; D Rating; W L Nyhan
Journal: J Inherit Metab Dis Date: 1993 Impact factor: 4.982